Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.

Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.

The cardiovascular safety of tiotropium Respimat formulation in the routine clinical practice is still an open issue. Our aim was to compare the risk of acute myocardial infarction and heart rhythm disorders in incident users of either tiotropium Respimat or HandiHaler. The study population comprise...

Full description

Bibliographic Details
Main Authors:	Francesco Trotta, Stefania Spila-Alegiani, Roberto Da Cas, Maja Rajevic, Valentino Conti, Mauro Venegoni, Mariangela Rossi, Giuseppe Traversa
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5400270?pdf=render

Similar Items

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis
by: Halpin DMG, et al.
Published: (2015-02-01)

Tiotropium HandiHaler&reg; in the treatment of COPD: A safety review
by: Steven Kesten, et al.
Published: (2009-10-01)

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®
by: Dekhuijzen PNR, et al.
Published: (2016-08-01)

Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studies
by: ZuWallack R, et al.
Published: (2014-10-01)

Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch
by: Hanada S, et al.
Published: (2015-01-01)

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®
by: Jill A. Ohar, et al.
Published: (2020-08-01)

Bronchodilator efficacy of 18 µg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial
by: Yildiz P, et al.
Published: (2016-11-01)

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
by: Pablo Altman, et al.
Published: (2018-06-01)

October 2013 Tucson pulmonary journal club: tiotropium Respimat
by: Eddib A, et al.
Published: (2013-11-01)

Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy
by: Mauro Carone, et al.
Published: (2020-06-01)

Tiotropium Respimat&reg; improves physical functioning in chronic obstructive pulmonary disease
by: Heike Rau-Berger, et al.
Published: (2010-10-01)

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results.
by: Judy M Bradley, et al.
Published: (2014-01-01)

Efficacy and safety of tiotropium Respimat&reg; SMI in COPD in two 1-year randomized studies
by: Eric Bateman, et al.
Published: (2010-06-01)

Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations
by: Tan CK, et al.
Published: (2016-09-01)

Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting
by: Steinmetz KO, et al.
Published: (2019-07-01)

Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat&reg; Soft Mist&trade; Inhaler in COPD
by: Hodder R, et al.
Published: (2011-04-01)

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies
by: LaForce C, et al.
Published: (2018-06-01)

The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies
by: Ichinose M, et al.
Published: (2016-08-01)

Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat fixed-dose combination for chronic obstructive pulmonary disease patients in Italy
by: Carl Selya-Hammer, et al.
Published: (2016-10-01)

Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.
by: Ken Ohta, et al.
Published: (2015-01-01)

Handy Ruler
by: Isaac J. Peled, et al.
Published: (2014-06-01)

HandyAPP
by: Oka Aragaki, Oscar Alberto Yoshihide, et al.
Published: (2019)

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)
by: Beeh KM, et al.
Published: (2016-02-01)

Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice
by: Christian Taube, et al.
Published: (2020-08-01)

Safety of switching between rituximab biosimilars in onco-hematology
by: Silvana A. M. Urru, et al.
Published: (2021-03-01)

Pharmacokinetics and tolerability (Study 1) with particular reference to ocular safety (Study 2) of tiotropium Respimat&reg; Soft Mist&trade; Inhaler: findings from two dose-ranging studies in healthy men
by: Ulrich Feifel, et al.
Published: (2008-10-01)

Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation
by: Orietta Zaniolo, et al.
Published: (2011-06-01)

Generic substitution of antidiabetic drugs in the elderly does not affect adherence
by: Francesco Trotta, et al.
Published: (2014-12-01)

Wild Gorillas Handy with a Stick.
Published: (2005-11-01)

Nicht ohne Handy ins Theater
by: Flo Staffelmayr
Published: (2020-09-01)

A handy new design paradigm
by: B. Bergelin, et al.
Published: (2011-02-01)

HANDY MICROSCOPIC CLOSE-RANGE VIDEOGRAMMETRY
by: F. Esmaeili, et al.
Published: (2017-09-01)

A Handy Account of Philosophy in Schools
by: Clinton Golding
Published: (2014-11-01)

Smokeless consumption of medical cannabis pharmacokinetics, safety and feasibility of the CannaHALER© a phase 1a study
by: Offir Ben-Ishay, et al.
Published: (2020-03-01)

Numerical and Experimental Investigation on Key Parameters of the Respimat<sup>®</sup> Spray Inhaler
by: Yi Ge, et al.
Published: (2021-12-01)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
by: Ichinose M, et al.
Published: (2018-07-01)

Lernen mit Kopf, Herz und Handy.
by: Thomas Knaus, et al.
Published: (2019-12-01)

REVIEW: Handy guide for dealing with ethnic reporting
by: Priestley Habru
Published: (2001-09-01)

A “Handy” tool for hypertension prediction: Dermatoglyphics
by: Ganesh Chakravathy P., et al.
Published: (2018-12-01)

Versteht Ihr Handy IP? - Drahtlose Internetanbindung
by: Dietrich, Thie
Published: (1998)